• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·000930.SZ
Share

COFCO Biotechnology Co., Ltd. Stocks

CN¥ 5.14Last Updated 30.09.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

CN¥ 1.43B

CN¥ 5.14
Key Takeaways

Risk factor

Strong trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

COFCO Biotechnology Co., Ltd., established in 1998 and headquartered in Bengbu, China, specializes in the comprehensive processing and manufacturing of agricultural products across China. Its extensive product portfolio includes a variety of corn-based starches, such as edible, special, waxy, and modified waxy types. The company also supplies an array of feed ingredients, including corn gluten meal, sprayed corn husk, corn germ meal, and distillers' dried grains with solubles (DDGS), as well as raw materials for fertilizers and glutamic acid residue. COFCO Biotechnology manufactures diverse sweeteners like fructose and functional sugar alcohols, alongside fuel and edible alcohols, and even liquors. Biochemicals such as monosodium glutamate, citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E are also key outputs. Beyond these, its offerings extend to various edible oils (including corn crude, corn germ, rapeseed, peanut, and soybean oil), a range of syrups (fructose, maltose, glucose, oligomeric isomalt, and beer syrups), and essential packaging solutions (plastic woven bags, barrels, container bags, and diverse paper products). Additional specialized products encompass corn fiber feed, bacterial protein, microorganisms, compound antioxidants, and nutritious health foods. COFCO Biotechnology also provides essential support services like warehousing, logistics, and information consulting. Furthermore, the company's operational scope is remarkably broad, encompassing research and development in biological engineering, the production and sale of amino acids and both compound and organic fertilizers, and the trade of chemical products and grains. Its activities extend to the wholesale and retail of edible agricultural products, the export of its own products and associated technologies, and the import of necessary raw materials, equipment, and technologies. The firm is also involved in steam production and sales, coal wholesale, food and food additive manufacturing and sales, house leasing, food procurement, power generation, and the distribution of pre-packaged, bulk, and dairy food items. The company underwent a rebranding in September 2019, transitioning from its former name, COFCO Biochemical (Anhui) Co., Ltd., to its current designation, COFCO Biotechnology Co., Ltd.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 000930.SZ is 7.70 and suggests 49.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

10.10.2026 16:01

What's Important in Small-Cap Stocks: Risks Associated with Webull, Levi's Outlook, and Vaxcyte's Success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

10.10.2026 06:47

Moderna hits four-year high as NYT reports U.S. cancer vaccine effort

10.10.2026 04:58

Palantir shares hit a new high: Barclays followed Goldman in recommending a buy

10.10.2026 04:25

Apple has cut orders for parts for the new iPhones, according to media reports. Was demand lower than expected?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026